✦ LIBER ✦

ABCB1 polymorphisms and the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under antiretroviral therapy

✍ Scribed by Estrela, Rita de Cassia; Ribeiro, Fabio S; Barroso, Paulo F; Tuyama, Mari; Gregório, Sheila P; Dias-Neto, Emmanuel; Struchiner, Cláudio J; Suarez-kurtz, Guilherme

Book ID: 120817276
Publisher: Future Medicine
Year: 2009
Tongue: English
Weight: 523 KB
Volume: 10
Category: Article
ISSN: 1462-2416
DOI: 10.2217/14622416.10.2.311

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of SLCO1B1 polymorphisms on t

The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men

✍ Fabiana B. Kohlrausch; Rita De Cássia Estrela; Paulo F. Barroso; Guilherme Suare 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

HIV-1 viral load in blood and semen plas

HIV-1 viral load in blood and semen plasma of Brazilian patients under antiretroviral therapy

✍ Roseane Porto Medeiros; Patrı́cia Munerato; Ricardo Sobhie Diaz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Dual therapy with lopinavir and ritonavi

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

✍ Cahn, Pedro; Andrade-Villanueva, Jaime; Arribas, José R; Gatell, José M; Lama, J 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 321 KB

Dendritic Cell Numbers in the Blood of H

Dendritic Cell Numbers in the Blood of HIV-1 Infected Patients Before and After Changes in Antiretroviral Therapy

✍ JENNIFER S. FINKE; MICHAEL SHODELL; KOKILA SHAH; FREDERICK P. SIEGAL; RALPH M. S 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 321 KB

Once-daily atazanavir/ritonavir versus t

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB

Long-term (96-week) follow-up of antiret

Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial

✍ J Ghosn; P Flandre; I Cohen-Codar; P-M Girard; M-L Chaix; F Raffi; P Dellamonica 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB